{"slideshow_credits": null, "snippet": "The decision could open the door to more generic drug production in India.", "abstract": "The decision could open the door to more generic drug production in India.", "section_name": "World", "print_page": null, "document_type": "blogpost", "byline": {"person": [], "original": "By THE NEW YORK TIMES", "organization": "The New York Times"}, "web_url": "http://india.blogs.nytimes.com/2012/03/13/india-orders-bayer-to-license-a-patented-drug/", "lead_paragraph": null, "headline": {"main": "India Orders Bayer to License a Patented Drug", "kicker": "India Ink"}, "_id": "4fd3a39e8eb7c8105d8ed3e0", "word_count": "185", "multimedia": [], "pub_date": "2012-03-13T01:06:22Z", "source": "The New York Times", "news_desk": null, "keywords": [], "blog": [], "subsection_name": "Asia Pacific", "type_of_material": "Blog"}